IV Acetaminophen and Patent Ductus Arteriosus
| Status: | Recruiting |
|---|---|
| Conditions: | Cardiology |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 1/23/2019 |
| Start Date: | January 2017 |
| End Date: | March 1, 2019 |
| Contact: | Kate Tauber, MD |
| Email: | tauberk@mail.amc.edu |
| Phone: | 518262-5421 |
The Efficacy of IV Acetaminophen on Patent Ductus Arteriosus Closure in Preterm Infants
This is a randomized controlled trial to evaluate the efficacy of IV acetaminophen versus IV
ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm
infants.
ibuprofen in closing a hemodynamically significant patent ductus arteriosus in preterm
infants.
Inclusion Criteria:
- preterm infants 23-30 weeks gestation,
- PDA requiring treatment
Exclusion Criteria:
- infection,
- congenital heart disease,
- genetic syndrome,
- NEC,
- pulmonary hypertension,
- hydrops,
- intestinal perforation,
- grade 3 or 4 IVH,
- serum creatinine >1.5,
- previous treatment with a COX inhibitor.
We found this trial at
1
site
Albany, New York 12208
Principal Investigator: Kate A Tauber, MD
Phone: 518-262-5421
Click here to add this to my saved trials
